ALT R&D to Revenue
Altimmune Inc · R&D to Revenue
ALT R&D to Revenue
Latest reported162029.27%period ending
ALT FY R&D/Revenue (0.00% → 162029.27%)
Latest values, visible window
High-resolution chart · PNG
ALT r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 162,029.2683% | |
| 411,130% | |
| 15,445.7746% | |
| -103,732.3529% | |
| 1,690.2721% | |
| 608.1144% | |
| 306.2287% | |
| 178.6759% | |
| 44,349.394% | |
| 92.4637% | |
| 48.2443% | |
| 91.4587% | |
| 85.3597% | |
| 77.4933% | |
| 87.4459% | |
| 99.4376% | |
| 109.6907% | |
| 96.661% | |
| 113.0846% | |
| 0% | |
| 0% |